MMJ accepts rival offer for subsidiaries

MMJ Phytotech has accepted a competing bid for the spin-out of its medical cannabis-focused Canadian subsidiaries onto the TSX Venture Exchange, with the new deal worth $C42 million ($A41 million).


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 28/02/19

1 year TSR5 year TSR
42ndSeafarms Group85%20%
206thFFI Holdings9%5%
411thXRF Scientific-23%-7%
567thMMJ Group Holdings-44%
730 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$0 Issued
$0 Bought
$0 Other
Total value as at the date of the transaction
Source: Morningstar


50th↑Seafarms Group$36.1m
51st↑FFI Holdings$35.4m
53rd↑MMJ Group Holdings$32.8m
54th↑XRF Scientific$24.3m
200 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer